Jack W. Schuler - 09 Dec 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Reporting relationship: 10%+ Owner
Issuer ticker: SLNO
Reported as of: 09 Dec 2022
Net transaction value: -$9,100
SEC form: 4
Accepted by SEC: 15 May 2023, 16:04:38 UTC
Prior SEC filing: 09 May 2023
Next SEC filing: 14 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Jack W. Schuler

Key filing fact

Jack W. Schuler filed Form 4 for SOLENO THERAPEUTICS INC (SLNO) on 15 May 2023.

Key facts

This page summarizes Jack W. Schuler's Form 4 filing for SOLENO THERAPEUTICS INC (SLNO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 May 2023, 16:04.

Change

Previous filing in this sequence was filed on 09 May 2023.
Current net transaction value: -$9,100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLNO transaction

Common Stock

Sale

Transaction value: $9,100
Shares: -10,000
Change %: -21%
Price: $0.9100^*
Shares after: 36,595
Date: 09 Dec 2022
Ownership: By Jack W. Schuler Living Trust
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jack W. Schuler is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

This late filing is due to an inadvertent administrative error.

Footnote F2

Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.